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1080-41 Porcine Model of Atherothrombotic Chronic Total 
Occlusion
LaVerne Prosser, J. J. Elliott, Mauli Aggrawal, Steven R. Bailey, UTHSCSA, San Antonio, 
TX, San Antonio, TX
Background: Chronic total occlusions (CTO) are a significant problem identifying
patients at increased risk of death and myocardial infarction. Currently, There are no
reproducible animal models for evaluation of new percutaneous devices in the treatment
of CTO. We proposed a novel model of CTO mimicing human fiberoatheroma.Thi model
could be used to understand the unique properties of fibrous CTO as well a new develop
new devices.
Methods: Ten common swine (Sous Scroufulae) were intubated and underwent selective
coronary artery catheterization. After selective engagement of either the right or circum-
flex coronary artery, an introducer sheath was advanced into the mid segment of the
artery. A proprietary L-LPPA 3-d microporous bioabsorbable polymer cylinder(PC) was
placed using a solid introducer. This polymer allows limited antegrade flow to occur
resulting in gradual occlusion of the artery over hours or days. The bioabsorbable poly-
mer is designed to be completely absorbed by 28 days with replacement of the polymer
by a dense fibrotic plaque.
Results: PC were successfully delivered to all ten animals. One animal, who received a
proximal PC delivery died from an acute anterior wall myocardial infarction. The remain-
ing 9 animals underwent repeat angiography with intravascular ultrasound at 10 days.
One of the 9 animals had spontaneous recanalization at the PC implant site from bridg-
ing collaterals. The remaining 8 animals had complete occlusion of the vessel distal to
the PC without collateral formation. Once the total occlusion was crossed, intravascular
ultrasound imaging was performed .using a mechanical imaging system (CVIS). After
imaging the animal was euthenized and the artery segment dissected.. The histopathol-
ogy demonstrated a fibrotic occlusion with minimal residual polymer and no calcification.
Conclusion: 1. We present a new porcine model for fibrous CTO in the coronary arteries
that allows reproducible occlusion at an early time point. 2. This model mimics human
non calcified occlusive atheroma. 3. This model may allow the development of new tech-
niques and devices for treatment of CTO
1080-42 Resting 12-Lead Electrocardiogram as a Reliable 
Predictor of Functional Recovery After Recanalization 
of Chronic Total Coronary Occlusions
Ralf Surber, Philipp Bahrmann, Gero Schwarz, Gerald S. Werner, Friedrich Schiller 
University, Jena, Germany
Background: In coronary artery disease with impaired left ventricular function nuclear
imaging techniques are extensively used to predict viable tissue with a sensitivity of 81%
to 93%, but lower specificity of 58% to 66%. We evaluated a classic diagnostic modality,
the resting ECG, for prediction of functional recovery after recanalization of chronic total
coronary occlusions (CTO).
Methods: A consecutive series of 62 patients (pts) with impaired left ventricular function
due to a CTO of either the right coronary artery (RCA) or left anterior descendens (LAD)
and successful recanalization were studied. The regional wall motion severity index
(WMSI) was assessed by the centerline method before recanalization and at follow-up
(5±1.4 months). The resting 12-lead ECG prior to recanalization was analyzed for Q
waves in the region of the recanalized coronary artery. In addition, the Selvester com-
plete QRS score (SS) and parameters of QT dispersion were calculated. Patients with
bundle brunch block or paced rhythm were excluded from the analysis. Angiography
revealed reocclusion at follow-up in 6 pts and therefore they were also excluded from the
final analysis.
Results: The SS in the baseline ECG was significantly correlated to subsequent
improvement in WMSI (p=0.01). Improvement in WMSI greater 1 SD/chord occurred in
44% of pts. Absence of Q waves in the region of the recanalized artery predicted
improvement with 89% sensitivity and 67% specificity. A concordant QRS-T wave pattern
in patients without Q waves had a 83% specificity for improvement in regional wall
motion. In a multivariate regression model, including clinical and ECG parameters, only
absence of Q waves in the region of the recanalized artery predicted regional recovery of
wall motion (p=0.003). On the other hand, Q waves in the recanalized region were highly
predictive for non-recovery (positive predictive value 89%).
Conclusion: Improvement in regional wall motion after successful recanalization of
CTO´s is predicted by resting 12-lead ECG with a sensitivity and specificity comparable
to costly and time-consuming nuclear imaging techniques. Q waves in a region of a CTO
are specific for tissue without contractile recovery.
1080-43 Successful Percutaneous Revascularization of Chronic 
Total Occlusions Is Associated With a Significant 
Survival Benefit in Nondiabetics
Hitinder S. Gurm, Deepak P. Vivekananthan, Deepak L. Bhatt, Patrick L. Whitlow, 
Stephen G. Ellis, The Cleveland Clinic Foundation, Cleveland, OH
Background: Registry data suggest that successful percutaneous revascularization of
chronic total occlusions (CTOs) is associated with a survival benefit. Data from BARI and
other trials suggest that diabetics derive a survival benefit from surgical over percutane-
ous revascularization.
Methods: We evaluated the interaction of diabetic status and successful revasculariza-
tion of CTOs on survival in a large single center registry. A total of 899 patients under-
went attempt at percutaneous coronary intervention (PCI) of CTOs at our institution over
a 10-year period. Long-term follow up was obtained using the social security death index.
Patients were divided into non- diabetics, non-insulin requiring diabetics and insulin
requiring diabetics. The mean follow up was 4.3 years
Results: The mean age of the cohort was 62 years with 75% (678) being men. There
were 622 non-diabetics, 165 non- insulin-requiring diabetics and 112 insulin-requiring
diabetics. Among the non-diabetics the procedure was a success in 316 and of these 28
(8.9%) died on follow up in comparison to 49 (16%) of the 306 in whom the procedure
was unsuccessful (P = 0.007). Among the non-insulin requiring diabetics the mortality
among the 86 patients with a successful procedure was 13 (15.1%) compared to 17
among the 79 (21.5%) with an unsuccessful procedure (P = 0.32). Among the insulin
requiring diabetics the long term mortality was 30.2 % (19/63) among those with a suc-
cessful procedure and 24.5 % (12/49) among those with an unsuccessful procedure (P =
0.53).
Conclusion: Successful PCI of CTOs is associated with a survival advantage in non-dia-
betics and a trend towards improved survival in non- insulin requiring diabetics while no
improvement in outcome of insulin dependent diabetics is seen.
1080-44 Preliminary Experience With the Front Runner Coronary 
Catheter, Novel Device Dedicated to Mechanical 
Revascularization of Chronic Total Occlusions
Dejan Orlic, Alaide Chieffo, Goran Stankovic, Giuseppe Sangiorgi, Flavio Airoldi, Nicola 
Corvaja, Matteo Montorfano, Iassen Michev, Giancarlo Vitrella, Antonio Colombo, EMO 
Centro Cuore Columbus, Milan, Italy, San Raffaele Hospital, Milan, Italy
Background. The novel device, the Frontrunner Coronary Catheter (FCC), dedicated to
mechanical recanalization of CTO, relies on blunt microdissections inside the plaque
allowing passage of guidewire through the plaque and adjunctive angioplasty. In this
study we evaluated procedural and clinical success, and safety of recanalization using
the FCC device.
ethods. The study included patients with de novo or restenotic CTO located in a native
coronary artery who failed a prior attempt with a mechanical guidewire (hydrophilic wires
or CTO dedicated wires) and patients with an occlusion considered unsuitable for
guidewire attempt
Results. Between October 2000 and June 2003, 50 patients with 50 CTO were included
in the study. The median age of occlusion was 8.7 months: 10 months (3.2 to 48 months)
according to clinical history and 5.5 months (3 to 108 months) according to prior angio-
gram. The mean occlusion length was 38.3±22.3 mm. Overall device success was 25
(50%): total device success in 17 (68%) and combined success in the remaining 8 (32%)
occlusions. Among the 50 occlusions, mechanical wires were first attempted in 32 (64%)
of them (median time 11 minutes, range 5 to 35) and in all these cases without success.
Following usage of FCC device (median time 27 minutes, range 10 to 55) angiographic
success was achieved in 17 (53%) of these lesions. In 18 occlusions the FCC device was
the first attempted device and angiographic success was obtained in 8 (44%) of them.
Out of these 8 occlusions total device success was obtained in 6 (75%) and combined
success in the remaining 2 (25%) lesions. Coronary perforations occurred in 9 (17.3%)
patients leading to tamponade in 2 patients who were treated with pericardiocentesis.
Serious adverse events occurred in 8 (15.7%) patients within 30 days follow-up. There
were 7 non-Q-wave myocardial infarctions (CK-MB>3x above upper normal limit) and
one sudden death seven days after the index procedure.
Conclusions. The use of FCC can help to increase the success to reopen total occlu-
sions which failed a mechanical wire or which are considered unsuitable for an attempt.
The risk of perforation due to wire or to FCC device is relatively high and it may decrease
with experience.
1080-45 Temporal Trends in the Treatment of Total Coronary 
Occlusions
Neil Sawhney, Kevin E. Kip, Helen A. Vlachos, Alice K. Jacobs, David O. Williams, Rhode 
Island Hospital, Providence, RI
Background: Success rates for treatment of totally occluded (TO) coronary arteries
have been lower than for arteries with less severe lesions. Whether refinements in tech-
niques and equipment now available have improved the outcomes of TO intervention is
unknown.
Methods: From the 1985-86 NHLBI PTCA Registry and the current NHLBI Dynamic
Registry (1997-2001), we assessed relative prevalence and success rates in treating TO
lesions (>99% stenosis, TIMI 0 flow) in consecutive TO patients (pts) with (n=563) and
without (n=453) acute myocardial infarction (AMI).
Results: The prevalence of TO lesions attempted in AMI pts decreased over time from
40% in the 1985-86 Registry to 33%, 25%, 21% in sequential Waves 1-3 of the Dynamic
Registry, respectively (P<0.0001). Similarly findings were observed among non-AMI pts,
from 14% in the 1985-86 Registry to 8%, 6%, 4% in Waves 1-3 of the Dynamic Registry,
respectively (P<0.0001). Rates of successful intervention improved in AMI TO pts from
65% in the 1985-86 Registry to 90%, 92%, and 88% in Waves 1-3 of the Dynamic Regis-
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try, respectively and to a lesser extent in non-AMI TO pts from 63% in the 1985-86 Regis-
try to 81%, 77%, and 78% in Waves 1-3 of the Dynamic Registry, respectively ( both
P<0.0001). Inability to cross the lesion was the most common reason for failure in both pt
groups. In multivariable analysis, the most consistent predictor of unsuccessful dilation of
TO lesions was location in a bypass graft for both acute MI (OR 6.06, CI 2.67 – 13.77)
and non-AMI pts (OR 4.08, CI 1.61 – 10.3). For non-AMI TO lesions, the presence of
thrombus was associated with success (OR 0.33, CI 0.17-0.63) while being supplied by
collaterals was not (OR 2.10, CI 1.20-3.68). Pt age, gender, smoking status did not pre-
dict failure.
Conclusions: In this investigation, TO lesions were attempted less frequently over time.
Success rates for non-AMI pts were lower than AMI pts, were higher than in the prior
decade but failed to increase above 80%. Increase in success rates could be related to
more restricted patient selection. Factors related to lesion chronicity were associated
with failure to dilate TO lesions in non-AMI pts.
1080-46 Inadequate Margins Remain a Major Source of Failure 
After Brachytherapy for Instent Restenosis: Analysis of 
255 Lesions With One-Year Follow-Up
Matthew Mick, Timothy Vellinga, Rakesh Jagetia, Kristen Dwyer, St. Luke's Medical 
Center, Milwaukee, WI
Background: Intracoronary brachytherapy (ICBT) has previously been shown to be effec-
tive for instent restenosis. Causes of failure have not been widely studied since the tech-
nique gained approval.
Methods: All patients treated with ICBT for instent restenosis in native coronary arteries
at our institution between March 2001 and March 2002 were followed for one year. ICBT
was performed using the Novoste Beta-Cath System (Novoste Corporation) in 248
lesions and the Galileo System (Guidant Corporation) in 7 lesions. The procedures were
performed by 29 cardiologists and 6 radiation oncologists in a busy tertiary care setting
during the first year of approval. Patients with recurrent symptoms or abnormal stress
tests underwent repeat angiography. A panel of two cardiologists and a radiation oncolo-
gist reviewed all angiograms obtained during follow-up and the corresponding baseline
studies. The initial ICBT angiogram was assessed for adequacy of radiation margins with
respect to the injured segment. The follow-up angiograms were assessed for presence of
restenosis in the ICBT segment (TLRS).
Results: A total of 255 lesions were treated in 224 patients during the study period. There
were 139 males (62%). Age of the patients was 66 ± 12 years. Reference vessel diame-
ter, as assessed by the initial operator, was between 3 and 4 mm in 237 lesions (93%)
and less than 3 mm in 18 lesions (7%). Follow-up angiography was performed in 127 of
the treated lesions (50%). The mean duration between ICBT and follow-up angiography
was 200 ± 84 days. TLRS was identified in 20 (7.8%) of the treated lesions. Nine of the
20 patients (45%) were found to have inadequate margins at the time of the initial ICBT
procedure. The remaining 11 patients had documented radiation failure (4.3% of total
treated patients).
Conclusion: Despite a large number of operators, with limited experience using a new
device, failure of ICBT in adequately treated patients was uncommon. The major source
of failure in our series was inadequate margins in the treated segment. Use of longer
radiation sources and diligence in maintaining adequate margins should improve out-
comes.
1080-63 The Real-World Clinical Practice of Intracoronary 
Radiation Therapy as Compared to Investigational Trials
Seung-Woon Rha, Pramod K. Kuchulakanti, Maureen C. Abbott, Katrina Barksdale, Ellen 
Pinnow, Rebecca Torguson, Michael Porrazzo, William O. Suddath, Augusto D. Pichard, 
Lowell F. Satler, Kenneth K. Kent, Ron Waksman, Washington Hospital Center, 
Washington, DC
Background: Intracoronary radiation therapy (IRT) is established as an effective treat-
ment for in-stent restenosis (ISR). We aimed to determine whether the 6-month clinical
outcomes of patients (pts) treated with market released, post approval radiation are
equivalent to those enrolled in the Washington Radiation for In-Stent restenosis Trials
(WRIST).
Methods: The clinical outcomes of 110 pts with 128 lesions receiving commercially avail-
able IRT (beta 18.4 - 45.7 Gy or gamma 18 Gy) was compared with 117 pts with 117
lesions who received investigational IRT either with gamma (n=65, 192 Ir, 15Gy WRIST)
or beta (n=52, 90Y, 20.6 Gy Beta WRIST). The Investigational Radiation group (IR)
received antiplatelet therapy for 1 mo and the Commercial Radiation group (CR) for 6 mo.
Results: The baseline characteristics were similar. Diabetes 41.7% in CR and 34.2% in
IR. Pts in the CR were treated with wider radiation margins. Use of additional stents was
similar (33.2% in CR vs 38.5% in IR, P=0.34) but atheroablation devices used in CR were
lower than in IR (15.0% vs 72.6%, P<0.001). Major cardiac clinical events; Any MI, TLR,
and TVR were significantly lower in the CR.
Conclusions: The “real world” clinical practice of IRT demonstrates lower events and
better clinical outcomes when compared with patients treated during the investigational
IRT trials. This is most likely a result of implementation of the lessons learned from the
clinical trials primarily using higher doses, wider margins and prolonged antiplatelet ther-
apy.
1080-64 Late Total Occlusion Versus Treatment Failure Without 
Late Thrombotic Occlusion in Patients After 
Intracoronary Radiation: Angiographic and Clinical 
Outcomes
Roswitha Wolfram, Gary Mintz, Neil J. Weissman, Pramod K. Kuchulakanti, Seung-Woon 
Rha, Eduard Cheneau, George Aggrey, Maureen C. Abbott, Natalie Gevorkian, Ellen E. 
Pinnow, Ron Waksman, Washington Hospital Center, Washinton, DC
Background: Treatment of in-stent restenosis (ISR) with intracoronary radiation therapy
(IRT) has become the mainstay of revascularization therapy. However, radiation failure,
which presents as either occlusion or restenosis, occurs in up to 25% of patients. Late
thrombotic occlusion (LTO) is the major cause for radiation related morbidity. This study
aimed to compare the outcomes of patients with LTO versus patients with renarrowing
without LTO after intracoronary radiation.
Methods: Five hundred thirty-three patients who failed previous gamma or beta radiation
presented with angiographic evidence of LTO (n=283) or renarrowing (n=248). Patients
were followed for a mean of 423.8 ± 408.8 days after the date of failure and the clinical
outcome was compared.
Results: Prevalence of prior MI and CABG was higher in patients with LTO (P=0.02,
P=0.009; respectively). Other angiographical and clinical baseline characteristics were
comparable between the two groups. Six- and 12-month clinical outcomes are displayed
in the table. TVR-MACE rates after 6 and 12 months was higher in patients presenting
with LTO versus patients without LTO (P=0.001, respectively); whereas death and Q-
wave MI rates were similar in both groups.
Conclusions: Patients with LTO after intracoronary radiation therapy for ISR are at an
increased risk for major cardiac events at 6 and 12 months. Prolonged antiplatelet ther-
apy is mandatory to prevent LTO. These patients may require special care once pre-
sented with LTO.
1080-65 Factors Impacting Five-Year Survival After 
Percutaneous Coronary Intervention for Chronic Total 
Occlusion
David M. Safley, Barry D. Rutherford, John A. House, Avinash Khanna, Warren L. 
Johnson, Lee V. Giorgi, Kenneth C. Huber, Steven B. Laster, Charles W. Barth, James A. 
Grantham, Steven P. Marso, Mid-America Heart Institute, Kansas City, MO, University of 
Missouri, Kansas City, MO
Background: It has been shown that survival improves following successful percutane-
ous coronary intervention (PCI) of chronic total occlusions (CTO). This study describes
the clinical and demographic factors associated with decreased long-term survival in a
large cohort of patients undergoing PCI of a CTO.
Methods: The Mid-America Heart Institute has maintained a registry of all coronary
interventions. 2,687 PCIs for CTO were performed between June 1980 and May 2003.
Clinical predictors of 5-year survival were examined to identify those variables that may
assist the physician in weighing the risk:benefit ratio of revascularization. Univariate pre-
dictors of mortality were entered into a multivariable logistic regression analysis and are
presented here.
Results: The highest odds ratio for death after PCI to a CTO was found in those with
poor left ventricular systolic function (ejection fraction <40%). History of heart failure and
chronic renal insufficiency were associated with greater than doubling of the mortality
rate.
Conclusions: These data highlight the adverse effect of these demographic and clinical
variables on outcomes after PCI upon CTO. This should not discourage the use of PCI,
as it does relieve angina, and may improve long-term survival if successful. Rather, it
Table. Clinical Events at 6 Months
Commercial IRT n (%) Investigational IRT n (%) P
Death 6/110 (5.5) 5/117 (4.3) 0.68
Any MI 3/110 (2.7) 16/117 (13.7) 0.003
Any Revascularization 20/124 (16.1) 40/117 (34.2) 0.001
TLR 11/128 (8.6) 27/117 (23.1) 0.002
TVR 15/128 (11.7) 35/117 (29.9) <0.001
All MACE 15/110 (13.6) 36/117 (30.8) 0.002
Table. Six and 12-month clinical outcomes of LTO vs no-LTO
Restenosis without LTO 
(n=283)
Restenosis with LTO 
(n=248)
P 
Value
Clinical outcome at 6 
months
TVR MACE, n (%) 58 (26.0) 80 (41.0) 0.001
TLR, n (%) 45 (20.2) 63 (32.6) 0.004
Clinical outcome at 12 
months
TVR MACE, n (%) 67 (36.4) 86 (54.1) 0.001
TLR, n (%) 51 (27.7) 66 (41.5) 0.008
